Wednesday, October 20, 2021

 Pharmacist Sentenced to Nearly 6 Years in Prison for Multimillion-Dollar Compounded Medicine Scam that Defrauded Health Care Plans

An Orange County pharmacist has been sentenced to 70 months in federal prison for submitting more than $13 million in claims for medically unnecessary compounded medication prescriptions, the Justice Department announced today.

 

4 days ago — Approval of July 15, 2021, Enforcement and Compounding Committee Meeting ... reporting requirements for pharmacies distributing compounded human drug ...

 

16 hours ago — Indian hospital pharmacies underscore US FDA norms on drug compounding at medical ... Some of these compounders seek to compound drugs under section 503A.

 

5 days ago — Calabasas Doctor Sentenced to 14 Months in Federal Prison for Accepting Bribes as Part of Compounded Medication Conspiracy.

 

5 days ago — Compounding drugs is often at the center of these fraud cases. It is the practice of combining, mixing, or altering medicine ingredients to create a new ..

 

1 day ago — Doctor sentenced in compounding scheme. A southern California doctor was sentenced to 14 months in prison for accepting nearly $800,000 in bribes and ...

 

Friday, October 15, 2021

 

Statutes and Regulations

3 days ago — Pharmacy Related Sections of Chapter 217 - Foods, Drugs and Poisons ... compounding, dispensing and repackaging of radiopharmaceuticals.

 Department of Justice

Office of Public Affairs

FOR IMMEDIATE RELEASE
Wednesday, October 13, 2021

Texas Pharmacist Pleads Guilty to Adulterating Drug Used in Cataract Surgeries

A Texas man pleaded guilty Tuesday to one count of adulterating a drug that was used in cataract surgeries.

According to court documents, Jack Randall Munn, 71, of Dallas, a licensed pharmacist and former owner of Guardian Pharmacy Services (Guardian), a Dallas pharmacy, oversaw the compounding of the drug for two outpatient Dallas surgical centers in 2016 and 2017. The drug, a combination of an antibiotic and a steroid, contained an excessive amount of an inactive ingredient that can damage sensitive eye tissue.

At the time of the events described in court documents, Munn represented to the surgical centers that Guardian could compound the drug in a manner safe for injection into patients’ eyes. However, the drug made by Guardian contained an excessive amount of the inactive ingredient, causing its purity and quality to fall below that which it was represented to possess.

Munn pleaded guilty to one misdemeanor count of distributing an adulterated drug in violation of the Federal Food Drug and Cosmetic Act. He is scheduled to be sentenced on Feb. 3, 2022 and faces a maximum penalty of one year in prison and a fine of up to $100,000. The federal magistrate judge who presided over Munn’s guilty plea will determine sentence after considering the U.S. Sentencing Guidelines and other statutory factors.

The U.S. Food and Drug Administration’s (FDA) Office of Criminal Investigations investigated the case.

Assistant Director John Claud, Senior Trial Counsel David A. Frank and Trial Attorney Sarah Williams of the Civil Division’s Consumer Protection Branch are prosecuting the case. Associate Chief Counsel for Enforcement Karen Towns with the FDA’s Office of Chief Counsel, and the U.S. Attorney’s Office for the Northern District of Texas provided valuable assistance in the case.

Topic(s): 
Prescription Drugs
Press Release Number: 
21-988

The former owner of a Texas-based compounding pharmacy has pleaded guilty to adulterating a drug after at least 43 patients were left blinded or had their ....

 

Pharmacist pleads guilty to adulterating drug linked to eye ...

2 days ago — The former owner of a Texas-based compounding pharmacy has pleaded guilty to adulterating a drug after at least 43 patients were left blinded or had their ...